Related Experiment Video
Updated: Aug 9, 2026

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents
Published on: June 10, 2013
When and how to use mood stabilizers during breastfeeding
1William S Middleton Memorial Veteran's Administration Hospital and University of Wisconsin Medical School, Madison, Wisconsin, USA
For many women with bipolar disorder, treatment with mood stabilizers is indicated to decrease the risk of a recurrence of depression, mania, or psychosis during the postpartum period. Because breastfeeding during this time exposes infants to these medications, a risk-benefit analysis is crucial for the mother and her physician when deciding whether to breastfeed. This article reviews the risks and benefits to mothers and nursing infants with regard to untreated mental illness, breastfeeding, and medication exposure during breastfeeding. Reports of breast milk and infant serum drug concentrations are summarized. Adverse events reported with lithium, valproate, and carbamazepine are also described. The current available data and their limitations are further summarized to allow physicians to assess more accurately the risks and benefits of the use of mood stabilizers during breastfeeding. Finally, a list of practical recommendations is provided.
For many women with bipolar disorder, treatment with mood stabilizers is indicated to decrease the risk of a recurrence of depression, mania, or psychosis during the postpartum period. Because breastfeeding during this time exposes infants to these medications, a risk-benefit analysis is crucial for the mother and her physician when deciding whether to breastfeed. This article reviews the risks and benefits to mothers and nursing infants with regard to untreated mental illness, breastfeeding, and medication exposure during breastfeeding. Reports of breast milk and infant serum drug concentrations are summarized. Adverse events reported with lithium, valproate, and carbamazepine are also described. The current available data and their limitations are further summarized to allow physicians to assess more accurately the risks and benefits of the use of mood stabilizers during breastfeeding. Finally, a list of practical recommendations is provided.
More Related Videos
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
05:04A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect
Published on: September 22, 2023
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Mania and Antimanic Drugs: Overview
Antidepressant Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Drug Dosing: Infants and Children
Drug Therapy
Antianxiety Medications